Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up

OBJECTIVE: To determine the safety and efficacy of long-term use of mizoribine by undertaking a 3-year post-marketing surveillance study. METHODS: Subjects were all lupus nephritis patients newly treated with mizoribine between 1 October 2003 and 30 September 2005 at contracted study sites. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Nobuyuki, Okada, Kenya, Sudo, Yohei, Itoh, Hiromichi, Yoshida, Hisao, Kuroda, Tatsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607187/
https://www.ncbi.nlm.nih.gov/pubmed/26770729
http://dx.doi.org/10.1177/2050312114533960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607187/
https://www.ncbi.nlm.nih.gov/pubmed/26770729
http://dx.doi.org/10.1177/2050312114533960

Ejemplares similares